News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
142 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2363)
Day
2 (2)
3 (145)
4 (188)
5 (190)
6 (124)
7 (71)
10 (179)
11 (91)
12 (168)
13 (122)
14 (57)
17 (142)
18 (120)
19 (151)
20 (179)
21 (55)
24 (93)
25 (131)
26 (123)
27 (118)
28 (134)
31 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Press Releases
Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo
March 17, 2025
·
5 min read
Press Releases
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates
March 17, 2025
·
11 min read
Press Releases
Qolab Secures Investment from Applied Ventures and Announces Collaboration to Advance Quantum Computing Manufacturing
March 17, 2025
·
2 min read
Press Releases
SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results
March 17, 2025
·
2 min read
Press Releases
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
March 17, 2025
·
7 min read
Press Releases
Evommune Initiates Phase 2 Trial of IL-18 Targeted Fusion Protein, EVO301, in Adult Patients with Atopic Dermatitis
March 17, 2025
·
3 min read
Press Releases
Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
March 17, 2025
·
4 min read
Press Releases
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
March 17, 2025
·
3 min read
Press Releases
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
March 17, 2025
·
11 min read
Press Releases
Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 17, 2025
·
11 min read
Previous
5 of 15
Next
